Publications

Publications

 

For each publication, click on the title for more information, including the abstract, complete citation, and access to the article. You will be redirected to the National Library of Medicine.

 

 

PubMed

Prion clearance in bigenic mice.
Safar JG
DeArmond SJ
Kociuba K
Deering C
Didorenko S
Bouzamondo-Bernstein E
Prusiner SB
Tremblay P
2-Aminothiazoles as therapeutic leads for prion diseases.
Gallardo-Godoy A
Gever J
Fife KL
Silber BM
Prusiner SB
Renslo AR
Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease.
Watts JC
Giles K
Grillo SK
Lemus A
DeArmond SJ
Prusiner SB
Prions.
Colby DW
Prusiner SB
A survey of antiprion compounds reveals the prevalence of non-PrP molecular targets.
Poncet-Montange G
St Martin SJ
Bogatova OV
Prusiner SB
Shoichet BK
Ghaemmaghami S
Copper induces conformational changes in the N-terminal part of cell-surface PrPC.
Leclerc E
Serban H
Prusiner SB
Burton DR
Williamson RA
Changes in neuropeptide expression in mice infected with prions.
Diez M
Groth D
DeArmond SJ
Prusiner SB
Hökfelt T
Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein.
Huang Y
Okochi H
May BC
Legname G
Prusiner SB
Benet LZ
Guglielmo BJ
Lin ET
Prion infection of mouse neurospheres.
Giri RK
Young R
Pitstick R
DeArmond SJ
Prusiner SB
Carlson GA
Inactivation of prions by acidic sodium dodecyl sulfate.
Peretz D
Supattapone S
Giles K
Vergara J
Freyman Y
Lessard P
Safar JG
Glidden DV
McCulloch C
Nguyen HO
Scott M
Dearmond SJ
Prusiner SB
Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro.
Kanaani J
Prusiner SB
Diacovo J
Baekkeskov S
Legname G
Solid-state NMR structural studies of the fibril form of a mutant mouse prion peptide PrP89-143(P101L).
Lim KH
Nguyen TN
Damo SM
Mazur T
Ball HL
Prusiner SB
Pines A
Wemmer DE